US-based Prolacta Bioscience, best known for its human milk-based nutritional fortifiers, is conducting a clinical trial assessing the effect of its products on the growth of premature infants in Japan.
Probiotics have boomed in China in recent years, accounting for almost half of Asia’s sales, but the nation’s infant nutrition market has begun slow, leading experts to call for more innovation and products with added functionality.
We spoke with industry experts from Nestle, Morinaga, Max Biocare and Shiseido to find out their 2022 predictions for health and nutrition trends, spanning insights across healthy ageing, infant nutrition, kids’, women’s, and men’s health.
See our 10 most-read regulatory stories of 2021, including Recommended Dietary Allowance (RDA) policies in India, South Korea’s monitoring of krill oil and probiotics, and new standards for fish oil in Thailand.
Yiling Pharmaceutical’s Lianhua Qingwen, NMN market boom, Nestle China’s ‘blue-hat’ certified health foods for seniors, and a2 milk market potential are some of the most popular China-related stories this year.
New insights into HMO levels in the breast milk of Chinese mothers has been detailed in a study funded by Abbott, in what is believed to be the first to cover a prolonged study period of 400 days postpartum.
See the 10 most-read stories in the month of November, including Nestle China's insights on the country's infant liquid milk market, Malaysia's Holista Colltech NPD plans for its highly popular probiotic brand Lacto-5, consumption trends...